Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics.
about
Molecular Pathways Bridging Frontotemporal Lobar Degeneration and Psychiatric DisordersThe Efficacy of Non-Pharmacological Interventions on Brain-Derived Neurotrophic Factor in Schizophrenia: A Systematic Review and Meta-AnalysisA longitudinal study of alterations of hippocampal volumes and serum BDNF levels in association to atypical antipsychotics in a sample of first-episode patients with schizophreniaSustained, neuron-specific IKK/NF-κB activation generates a selective neuroinflammatory response promoting local neurodegeneration with aging.Theranostic Biomarkers for SchizophreniaIn SilicoModel-driven Assessment of the Effects of Brain-derived Neurotrophic Factor Deficiency on Glutamate and Gamma-Aminobutyric Acid: Implications for Understanding Schizophrenia Pathophysiology.Increased serum brain-derived neurotrophic factor in male schizophrenic patients with metabolic syndrome.Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis.Genetics of serum BDNF: meta-analysis of the Val66Met and genome-wide association studySerum brain-derived neurotrophic factor (BDNF) levels in schizophrenia: A systematic reviewBDNF Val66Met variant and smoking in a Chinese population.New insight in expression, transport, and secretion of brain-derived neurotrophic factor: Implications in brain-related diseases.Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndromePeripheral BDNF: a candidate biomarker of healthy neural activity during learning is disrupted in schizophrenia.BDNF-TrkB signaling and neuroprotection in schizophreniaA Review of Brain-derived Neurotrophic Factor as a Candidate Biomarker in Schizophrenia.Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls.Gender-specific Associations of the Brain-derived Neurotrophic Factor Val66Met Polymorphism with Neurocognitive and Clinical Features in SchizophreniaFactors associated with response to clozapine in schizophrenia: a review.Vascular endothelial growth factor and brain-derived neurotrophic factor in quetiapine treated first-episode psychosis.Diagnostic Accuracy of Brain-derived Neurotrophic Factor and Nitric Oxide in Patients with Schizophrenia: A pilot studyThe neurotrophins and their role in Alzheimer's disease.The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence.Interaction of sex steroid hormones and brain-derived neurotrophic factor-tyrosine kinase B signalling: relevance to schizophrenia and depression.Lithium's role in neural plasticity and its implications for mood disordersThe Val66Met brain-derived neurotrophic factor gene variant interacts with early pain exposure to predict cortisol dysregulation in 7-year-old children born very preterm: Implications for cognition.Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study.Brain-Derived Neurotrophic Factor Expression in Individuals With Schizophrenia and Healthy Aging: Testing the Accelerated Aging Hypothesis of Schizophrenia.Serum brain-derived neurotrophic factors in Taiwanese patients with drug-naïve first-episode schizophrenia: Effects of antipsychotics.BDNF Val66Met Genotype Interacts With a History of Simulated Stress Exposure to Regulate Sensorimotor Gating and Startle Reactivity.A method for the detection of meaningful and reproducible group signatures from gene expression profiles.Rai1 haploinsufficiency causes reduced Bdnf expression resulting in hyperphagia, obesity and altered fat distribution in mice and humans with no evidence of metabolic syndrome.The search for new biomarkers for cognition in schizophrenia.Low BDNF is associated with cognitive deficits in patients with type 2 diabetes.Sex-dependent alterations in BDNF-TrkB signaling in the hippocampus of reelin heterozygous mice: a role for sex steroid hormones.Association of serum brain derived neurotropic factor with duration of drug-naive period and positive-negative symptom scores in drug naive schizophrenia.Can BDNF and IL-2 be indicators for the diagnosis in schizophrenic patients with depressive symptoms?Brain-derived neurotrophic factor serum and plasma levels in the treatment of acute schizophrenia with olanzapine or risperidone: 6-week prospective study.Altered BDNF is correlated to cognition impairment in schizophrenia patients with tardive dyskinesia.Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia.
P2860
Q26766487-FB117841-BB95-449C-B7FD-6B44A1BD240BQ28066603-381434D5-EA46-4BD5-A945-8A249A95C885Q28539784-81A3F396-D06D-47C1-BCBE-734890A95CB1Q30557279-1B647CE1-CC59-4CE1-860E-BA7FB2361ACDQ33624412-DE4A00C0-4EF7-467B-9EF8-C65DA79DB623Q33662831-20EDE3C3-A6D6-4B32-B14F-A528927F0587Q33765625-D9B601D8-41D5-4A3D-BA9B-92E4424783BFQ34132832-53840E48-3214-4D0A-84BD-37C859286784Q34229583-C16B56D7-A915-4429-ABEB-1569418229CFQ34347464-BE235F8F-FEB6-4926-B762-305064C0ACACQ34535122-4A4D9DA2-0A1C-4023-8A57-F57A989A1A35Q34567939-6CF315FD-B74E-4B91-9324-94A32FADADC8Q35284133-55E9E567-A04A-4D9D-AED6-ACD650814E3BQ35550864-71EF64A6-5F4E-4DE3-8340-26889F8F2AEBQ36589545-3420FA31-A9E1-4219-B06F-A00078F5E21BQ36600804-32CA828C-EAA2-43B5-95E2-C5C891291082Q36900676-7ECDA1E9-4F8C-4B5F-9E8B-FC1916122175Q37160615-A98B91B9-8BFB-4B56-882C-385E9B343756Q37300007-D50CF180-81A1-4DF5-AEE3-4102BA852254Q37615022-E4E64C7B-EF33-45BF-91D6-8BD8DFBB7A7AQ37694923-60E1B557-927F-41A7-AA34-A1CED358EB33Q38015342-D99FC9ED-796B-4F6F-874F-506975A3E38AQ38025454-E0B68101-0A9D-4F6B-8AB6-1E292E9F7F04Q38030630-CF7548E9-25C0-4CC3-9C38-E51739B0CE95Q38101644-91EC02F4-D16F-4692-9345-E24C74D07CD3Q38575985-67B6FB94-4468-4E42-ACDB-B73C6820C12AQ38760788-CBCFCE0D-6307-4745-9A87-B625DE0D3ACAQ38769563-A9F4975D-4E63-4897-A01E-4EC6EB285183Q38819864-826DE53D-23EF-4AEB-BCF4-07849C53B371Q39709894-20414764-9E65-4E22-B35A-F1A7E3DE37DCQ42607091-3BBF531D-FE15-4E2F-80DB-07847D2D8317Q42955370-3AE52539-BA70-47FA-963B-91DF0228B641Q43376611-BF1BEB3F-B1EE-431B-A588-474F4817402BQ44345365-558D7761-6005-453F-AB23-D3109A5DF774Q45009772-0119A0C9-3E5B-4954-ADDF-EFCD117FBA76Q47559874-EB0336E3-D79D-4894-8BE3-2EBB29DD62E5Q48208291-C9AF7FB2-B9D7-4FB5-BBC7-D0ADDF8DD204Q48215288-BBE9D312-A520-418D-ABCF-95F34A7F14C5Q48678119-26C6BFF9-CC41-4065-BB2B-A92F3860933BQ48694105-E63B07EA-644F-4E02-9F6A-E19FD4ED56E2
P2860
Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Decreased serum BDNF levels in ...... l and atypical antipsychotics.
@ast
Decreased serum BDNF levels in ...... l and atypical antipsychotics.
@en
Decreased serum BDNF levels in ...... l and atypical antipsychotics.
@nl
type
label
Decreased serum BDNF levels in ...... l and atypical antipsychotics.
@ast
Decreased serum BDNF levels in ...... l and atypical antipsychotics.
@en
Decreased serum BDNF levels in ...... l and atypical antipsychotics.
@nl
prefLabel
Decreased serum BDNF levels in ...... l and atypical antipsychotics.
@ast
Decreased serum BDNF levels in ...... l and atypical antipsychotics.
@en
Decreased serum BDNF levels in ...... l and atypical antipsychotics.
@nl
P2093
P1476
Decreased serum BDNF levels in ...... l and atypical antipsychotics.
@en
P2093
Chong Xi Zhang
Da Chun Chen
Mei Hong Xiu
Thomas R Kosten
Tian De Hou
Xiang Yang Zhang
You Lan Zheng
Yu Feng Dang
P304
P356
10.1016/J.PNPBP.2009.08.011
P577
2009-08-29T00:00:00Z